EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The hyaluronan receptor CD44 drives COVID-19 severity through its regulation of neutrophil migration

Duncan J Hart iD, Md Jashim Uddin, Rebecca J Dodd, Savannah G Brovero, Claire Fleming, Gregory Brett Moreau, Nick R Natale, Farha Naz, Barbara J Mann, Tara E Sutherland, Judith E Allen, Anthony J Day und 1 weitere

PLOS Pathogens · 20.05.2026 · 22 (5) · e1013619

DOI: 10.1371/journal.ppat.1013619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 20.05.2026. Verfasst von Duncan J Hart und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, Virginia, United States of Ame…. Hauptthemen laut MEDLINE: Hyaluronan Receptors, COVID-19, Neutrophils, Neutrophil Infiltration. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The novel respiratory disease COVID-19 caused by the coronavirus SARS-CoV-2 continues to be a public health emergency worldwide, and there is a need for more effective therapy for patients. The relationship between the extracellular matrix and the host immune response to infection is severely understudied. Deposition of the polysaccharide hyaluronan (HA) into the lungs is associated with more severe COVID-19 disease outcomes. HA is a major component of the extracellular matrix in connective tissues and is abundant in many parts of the body, including cartilage, skin, brain, and vitreous body. HA is a major component of the extracellular matrix in connective tissues and is abundant in many parts of the body, including cartilage, skin, brain, and vitreous body. Polymers consist of repeating units of N-acetylglucosamine and glucuronic acid and are synthesized by the three hyaluronan synthase (HAS) enzymes, HAS1–3. CD44 is the primary receptor for HA and is found on almost all immune cells in the lung. Known functions of CD44 include mediation of immune cell migration, activation, and differentiation. We hypothesized that increased HA deposition during COVID-19 increases CD44-mediated immune cell infiltration into lungs and results in more severe pathology. Here, we report that in mice infected with a mouse-adapted strain of SARS-CoV-2, treatment with a combination of two anti-CD44 monoclonal antibodies confers a significant survival benefit and reduces weight loss and clinical score of the mice on Day 4 post infection. We show that anti-CD44 treatment decreases many key cytokines and chemokines in the bronchoalveolar lavage fluid on Day 4. With flow cytometry, we show that anti-CD44 reduces the numbers of neutrophils in infected lungs. We also show through immunofluorescence that treatment with anti-CD44 antibodies reduces colocalization of HA and CD45 in lung sections, indicating that HA’s interaction with immune cells contributes to pathology. Our findings demonstrate that disruption of HA-receptor interactions is a way to prevent inflammatory pathology in pulmonary infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronan ReceptorsCOVID-19NeutrophilsNeutrophil InfiltrationAnimalsMiceSARS-CoV-2Hyaluronic AcidLungHumansFemaleCell MovementPandemicsMice, Inbred C57BL

Substanzen

Hyaluronan ReceptorsHyaluronic Acid

Autor:innen und Institutionen

  • Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, Virginia, United States of America.
  • Lydia Becker Institute of Immunology and Inflammation, School of Biological Sciences, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.
  • Manchester Cell-Matrix Centre, School of Biological Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.
  • Division of Infectious Diseases and International Health, University of Virginia School of Medicine, Charlottesville, Virginia, United States of America.
  • Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, United States of America.
  • Department of Neuroscience, Center for Brain Immunology and Glia (BIG), University of Virginia, Charlottesville, Virginia, Unites States of America.

ORCID-Profile: Duncan J Hart, William A Petri

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases
  • Manning Family Foundation
  • Wellcome Trust
  • Robert and Dr. Lisa Henske

Zitieren

APA

Hart, D. J., Uddin, M. J., Dodd, R. J., Brovero, S. G., Fleming, C., Moreau, G. B., Natale, N. R., Naz, F., Mann, B. J., Sutherland, T. E., Allen, J. E., Day, A. J., & Petri, W. A. (2026). The hyaluronan receptor CD44 drives COVID-19 severity through its regulation of neutrophil migration. PLOS Pathogens, 22(5), e1013619. https://doi.org/10.1371/journal.ppat.1013619

Vancouver

Hart DJ, Uddin MJ, Dodd RJ, Brovero SG, Fleming C, Moreau GB, et al. The hyaluronan receptor CD44 drives COVID-19 severity through its regulation of neutrophil migration. PLOS Pathogens. 2026;22(5):e1013619. doi:10.1371/journal.ppat.1013619

BibTeX
@article{Hart2026,
  author = {Hart, Duncan J and Uddin, Md Jashim and Dodd, Rebecca J and Brovero, Savannah G and Fleming, Claire and Moreau, Gregory Brett and Natale, Nick R and Naz, Farha and Mann, Barbara J and Sutherland, Tara E and Allen, Judith E and Day, Anthony J and Petri, William A},
  title = {The hyaluronan receptor CD44 drives COVID-19 severity through its regulation of neutrophil migration},
  journal = {PLOS Pathogens},
  year = {2026},
  volume = {22},
  number = {5},
  pages = {e1013619},
  doi = {10.1371/journal.ppat.1013619}
}
Kostenlos starten →